Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
Shohreh Alipour, Laleh Mahmoudi, Fatemeh Ahmadi
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 705-715
Open Access | Times Cited: 23

Showing 23 citing articles:

Empowering Precision Medicine: The Impact of 3D Printing on Personalized Therapeutic
Lorca Alzoubi, Alaa A. A. Aljabali, Murtaza M. Tambuwala
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Open Access | Times Cited: 39
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 15
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Eknath Kole, Krishna Jadhav, Nitin Shirsath, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104261-104261
Closed Access | Times Cited: 30
A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
Hend I. Shahin, Lipika Chablani
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104553-104553
Closed Access | Times Cited: 25
mRNA nanodelivery systems: targeting strategies and administration routes
Mujie Yuan, Zeyu Han, Yan Liang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Citrus clementine Peel Essential Oil Ameliorates Potassium Dichromate-Induced Lung Injury: Insights into the PI3K/AKT Pathway
Hany G. Attia, Suzan M. El-Morshedy, Ahmed M. Nagy, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 7
Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis
Bo Ran, Xiaohong Ren, Xueyuan Lin, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 811-820
Closed Access | Times Cited: 4
Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges
Pushpa Raj Joshi
Geriatrics (2024) Vol. 9, Iss. 2, pp. 34-34
Open Access | Times Cited: 3
Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections
Brayan J. Anaya, Davide D’Angelo, Ruggero Bettini, et al.
Carbohydrate Polymers (2024) Vol. 348, pp. 122930-122930
Closed Access | Times Cited: 3
Liposomal drug delivery to the lungs: a post covid-19 scenario
Sivadas Swathi Krishna, M. S. Sudheesh, Vidya Viswanad
Journal of Liposome Research (2023) Vol. 33, Iss. 4, pp. 410-424
Closed Access | Times Cited: 9
Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies
Sarah Hamdy Ahmed, Mohamed Atef AlMoslemany, Kenneth W. Witwer, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 900-930
Open Access | Times Cited: 2
Impact of Nebulization on the Physicochemical Properties of Polymer–Lipid Hybrid Nanoparticles for Pulmonary Drug Delivery
Andrea Gonsalves, Jyothi U. Menon
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5028-5028
Open Access | Times Cited: 2
Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs
Lea-Adriana Barlang, Isabelle Deimel, Björn-Patrick Mohl, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 196, pp. 106744-106744
Open Access | Times Cited: 1
The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
Gabriella Guarnieri, Matteo Iervolino, Sara Cavallone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6959-6959
Open Access | Times Cited: 4
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
Hailong Guo, Bomsoo Cho, Paul R. Hinton, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Development and Approval of a Multidimensional Model of the Clinical Effectiveness of Treatment Technologies for Patients With a Mild COVID-19 Associated With Comorbidities
О.К. Yakovenko, Serhii O. Soloviov, MykhailoP Smetiukh, et al.
Innovative Biosystems and Bioengineering (2024) Vol. 8, Iss. 1, pp. 19-36
Open Access
In vivo quantitative characterization of nano adjuvant transport in the tracheal layer by photoacoustic imaging
Chaohao Liang, Fan Meng, Yiqing Zhang, et al.
Biomedical Optics Express (2024) Vol. 15, Iss. 6, pp. 3962-3962
Open Access
Mathematical Modeling of the Drug Particles Deposition in the Human Respiratory System—Part 1: Development of Virtual Models of the Upper and Lower Respiratory Tract
Natalia Menshutina, Elizaveta Mokhova, Andrey Abramov
Computation (2024) Vol. 12, Iss. 7, pp. 134-134
Open Access
pH-sensitive prodrugs
Emanuela Berrino, Sébastien Thibaudeau
Elsevier eBooks (2024), pp. 23-40
Closed Access
Functionalized nanostructures and targeted delivery systems with a focus on plant-derived natural agents for COVID-19 therapy: A review and outlook
Khaled AbouAitah, Beom Soo Kim, Witold Łojkowski
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access
Health-Related Quality of Life (HRQoL) in COVID-19 Patients After Recovering from the Acute Infection
Dena Firouzabadi, Laleh Mahmoudi, Maryam Kadkhodamohammadi, et al.
Archives of Pediatric Infectious Diseases (2024) Vol. 12, Iss. 4
Open Access
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
Hailong Guo, Bomsoo Cho, Paul R. Hinton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
CLINICAL EFFICACY AND SAFETY OF AMINOCAPROIC ACID IN THE TREATMENT OF PATIENTS WITH MILD COVID-19 AND THE PRESENCE OF RISK FACTORS FOR DISEASE PROGRESSION
O. К. Yakovenkо, Oleksandr Dziublyk, G. B. Kapitan, et al.
Ukrainian Pulmonology Journal (2023) Vol. 31, Iss. 3, pp. 27-32
Open Access
Page 1

Scroll to top